Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (6 ops.)
Latest filing published 23 Sept 2026 for Viavi Solutions INC.. Read the official filing
Filing timeline
BuySaleIlan Daskal
Insider track record
Disclosed buys
0
Disclosed sells
6
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Ilan Daskal: trading record in brief
Filings by Ilan Daskal span 3 companies, the busiest being Viavi Solutions Inc., Bio-Rad Laboratories, Inc. and Natus Medical Inc. We count 29 filings; the first trade dates from 11 June 2021 and the latest from 22 September 2026.
No open-market purchase appears, only 6 sales worth €3.1M. The rest of the record consists of 7 share grants and 15 option exercises. 2026 to date brings no purchases and 2 sales.
The record was last updated on 23 September 2026 with an option exercise in Viavi Solutions Inc. The median gap between a trade and its publication by SEC (Form 4) is 3 days. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Ilan Daskal
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations29 total
82,671 shares0Common StockSEC:0000912093-26-000084:0
37,285 shares@ US$36.40Common StockSEC:0000912093-26-000084:1
71,127 shares0Common StockSEC:0000912093-26-000084:2
32,079 shares@ US$36.40Common StockSEC:0000912093-26-000084:3
55,114 shares0Common StockSEC:0000912093-26-000072:0
24,857 shares@ US$36.540.010% mcap18.3% of flowCommon StockSEC:0000912093-26-000072:1
47,420 shares0Common StockSEC:0000912093-26-000072:2
21,387 shares@ US$36.540.0086% mcap15.7% of flowCommon StockSEC:0000912093-26-000072:3
30,257 shares@ US$36.290.012% mcap22.2% of flowCommon StockSEC:0000912093-26-000074:0
26,033 shares@ US$36.290.010% mcap19.1% of flowCommon StockSEC:0000912093-26-000074:1
25,100 shares@ US$17.8436.6% of flowCommon StockSEC:0000912093-25-000213:0
62,645 shares0Common StockSEC:0000912093-25-000207:0
70,545 shares0Common StockSEC:0000912093-25-000129:0
55,115 shares0Common StockSEC:0000912093-25-000102:0
82,095 shares@ US$9.28100.0% of flowCommon StockSEC:0000912093-25-000075:0
39,783 shares0Common StockSEC:0001127602-24-028243:0
694 shares0Bio-Rad A Common StockSEC:0001062993-23-017644:0
243 shares@ US$466.246.2% of flowBio-Rad A Common StockSEC:0001062993-23-009008:1
700 shares0Bio-Rad A Common StockSEC:0001062993-23-009008:0
541 shares0Bio-Rad A Common StockSEC:0001062993-22-019274:0
455 shares0Bio-Rad A Common StockSEC:0001062993-22-019183:0
18,937 shares@ US$33.5063.0% of flowCommon Stock, $0.001 par value per shareSEC:0000878526-22-000092:0
5,075 shares0Common Stock, $0.001 par value per shareSEC:0000878526-22-000041:0
700 shares0Bio-Rad A Common StockSEC:0001062993-22-010014:0
270 shares@ US$820.0620.8% of flowBio-Rad A Common StockSEC:0001062993-21-008354:0
25 of 29 declarations
